« Kudos |
Main
| Upcoming Conference: Return on Innovation »
October 7, 2003
Mea Culpa!
Posted by Renee Hopkins Callahan
I made a serious mistake in transcribing my notes from Innovation Convergence. In recounting the remarks of Dr. Stephen Oesterle from Medtronic, I wrote "tolerance for delusion by investors" when he actually said "tolerance for dilution by investors." Investor delusion may have been a reality in 1999, but not necessarily so today...and in any case that's a pretty catastrophic mis-rendering of what Dr. Oesterle said, as he was rightly quick to point out to me. I've corrected the original post, and I'm including the corrected version of Dr. Oesterle's remarks here so you don't have to go back and see the context:
Stephen N. Oesterle, M.D., Senior Vice President Medicine and Technology, Medtronic, described himself as a “technology scout who has to keep an eye on 2008.” His “yes” challenges: How do you innovate in a company where there’s no tolerance for dilution by investors? and how to keep on top of the convergence of biotech and medical devices that is the future of medical innovation.
Comments (0)
| Category: Conferences
- RELATED ENTRIES
- › Innovation Of A Tradition
- › We Hear Them, But Do We Know What They're Saying?
- › Farewell from Renee -- but check out the new IdeaFlow blogroll!
- › Supernova 2007 blog conversation: It's all about innovation and value
- › Innovation Bloggers Virtual Forum cancelled!!!
- › Join us at the first-ever Innovation Bloggers Virtual Forum, Thursday, April 26
- › Jack’s Notebook: A Business Novel of ‘Deliberate Creativity’
- › Models for crowdsourcing -- now, FLIRT
Renee Hopkins Callahan started IdeaFlow and serves as chief blog-wrangler. She is 
